Filing Overview
Registrant: 8i Acquisition 2 Corp. The request identifies EUDA Health Holdings Ltd., but the filing is by 8i Acquisition 2 Corp., a British Virgin Islands special purpose acquisition company. The Form 8-K was filed August 17, 2022, regarding an event occurring August 16, 2022.
Business Context and Reporting Period
The filing reports the creation of a direct financial obligation under Item 2.03. It does not provide operating results or financial statements for a reporting period.
Financial Metrics and Liquidity
- New obligation: The company issued an unsecured promissory note with principal of $200,000.
- Interest: The note bears no interest.
- Maturity: The note matures upon the closing of a business combination.
- Conversion feature: The holder may convert the note into units identical to those issued in the initial public offering at $10.00 per unit.
- Revenue, profit, cash flow, margins, debt balances, and liquidity: The filing does not provide clear values for these metrics.
Material Changes and Unusual Items
On August 16, 2022, the company created a $200,000 unsecured obligation to Tan Meng Dong (James), its Chief Executive Officer and Chairman of the Board. The related-party note is convertible into IPO-type units and is contingent in maturity on completion of a business combination.
Outlook, Risks, and Contingencies
- The note’s maturity depends on the closing of a business combination, creating a contingent repayment or conversion obligation.
- Conversion could result in the issuance of additional units and potential dilution to existing security holders.
- The filing provides no management guidance, transaction target update, or broader outlook.
- The filing does not describe the use of proceeds or the company’s ability to repay the note if a business combination is not completed.
Investor Verification Items
- Verify that the filing registrant is 8i Acquisition 2 Corp., not EUDA Health Holdings Ltd.
- Review the August 16, 2022 promissory note, filed as Exhibit 10.1, for conversion mechanics and other terms.
- Assess the potential dilution from conversion at $10.00 per unit.
- Confirm the company’s business-combination timeline and repayment treatment if no transaction closes.
- Review subsequent filings for repayment, conversion, amendment, or additional related-party financing.